Clincosm LogoSign in Get a demo

neuromyelitis optica spectrum disorders

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorders
  • (no location specified)
Sep 29, 2023

Neuromyelitis Optica Spectrum Disorders, Pain Trial in Guangzhou (electroacupuncture)

Completed
  • Neuromyelitis Optica Spectrum Disorders
  • Pain
  • electroacupuncture
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Chinese Medicine
May 20, 2023

Neuromyelitis Optica Spectrum Disorders Trial in Russian Federation (divozilimab, Placebo)

Recruiting
  • Neuromyelitis Optica Spectrum Disorders
  • divozilimab
  • Placebo
  • Barnaul, Russian Federation
  • +18 more
Feb 17, 2023

Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica Spectrum Related Disorders Trial in Bron

Completed
  • Neuromyelitis Optica Spectrum Disorders
  • Neuromyelitis Optica Spectrum Related Disorders
    • Bron, France
      Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer
    Mar 29, 2022

    An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit

    Completed
    • Neuromyelitis Optica Spectrum Disorders
      • Fuzhou, Fujian, China
      • +1 more
      Jan 19, 2022

      MS-ResearchBiomarkerS

      Recruiting
      • Multiple Sclerosis
      • +10 more
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Jan 26, 2022

        Neuromyelitis Optica Spectrum Disorders Trial in Beijing (Placebo, RC18 160 mg)

        Recruiting
        • Neuromyelitis Optica Spectrum Disorders
        • Placebo
        • RC18 160 mg
        • Beijing, Beijing, China
          Beijing Hospital
        Jan 9, 2022

        Neuromyelitis Optica Spectrum Disorders Trial in Shanghai (BAT4406F)

        Unknown status
        • Neuromyelitis Optica Spectrum Disorders
        • Shanghai, Shanghai, China
          Huashan Hospital affiliated to Fudan University
        Oct 29, 2019

        Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica Trial in Tianjin (Tocilizumab Injection, Azathioprine)

        Completed
        • Neuromyelitis Optica Spectrum Disorders
        • Neuromyelitis Optica
        • Tianjin, Tianjin, China
          Tianjin Medical University General Hospital
        Oct 22, 2019

        Among Chinese Neuromyelitis Optica Spectrum Disorders

        Unknown status
        • Neuromyelitis Optica Spectrum Disorders
          • Guangzhou, China
            Wei Qiu
          Oct 15, 2019

          Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica, Devic's Disease Trial in Tianjin (Tocilizumab)

          Completed
          • Neuromyelitis Optica Spectrum Disorders
          • +2 more
          • Tianjin, Tianjin, China
            Tianjin Medical University General Hospital
          Oct 15, 2018

          The French Multiple Sclerosis Registry

          Unknown status
          • Multiple Sclerosis
          • Neuromyelitis Optica Spectrum Disorders
            • Bron, France
              Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer
            Sep 6, 2016

            Multimodel Magnetic Resonance Imagingof Multiple Sclerosis and

            Unknown status
            • Multiple Sclerosis
            • Neuromyelitis Optica Spectrum Disorders
            • Magnetic Resonance Imaging
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Aug 7, 2016

            Neuromyelitis Optica Spectrum Disorders, Mycophenolate Mofetil, Efficacy and Safety Trial (Mycophenolate mofetil, Prednisone)

            Unknown status
            • Neuromyelitis Optica Spectrum Disorders
            • +2 more
            • (no location specified)
            Jun 19, 2016

            Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders Trial in Beijing (Mitoxantrone)

            Unknown status
            • Neuromyelitis Optica
            • Neuromyelitis Optica Spectrum Disorders
            • Beijing, Beijing, China
              Department of Neurology, Xuanwu Hospital, Capital Medical Univer
            Dec 19, 2013